Reliable direct measurement of causes of death in low- and middle-income countries by Prabhat Jha
Medicine for Global Health
Jha BMC Medicine 2014, 12:19
http://www.biomedcentral.com/1741-7015/12/19OPINION Open AccessReliable direct measurement of causes of death
in low- and middle-income countries
Prabhat JhaAbstract
Background: Most of the 48 million annual deaths in low- and middle-income countries (LMICs) occur without
medical attention at the time of death so that the causes of death (COD) are largely unknown. A review of low-cost
methods of obtaining nationally representative COD data is timely.
Discussion: Despite clear historic evidence of their usefulness, most LMICs lack reliable nationally representative COD
data. Indirect methods to estimate COD for most countries are inadequate, mainly because they currently rely on an
average ratio of 1 nationally representative COD to every 850 estimated deaths in order to measure the cause of 25
million deaths across 110 LMICs. Direct measurement of COD is far more reliable and relevant for country priorities.
Five feasible methods to expand COD data are: sample registration systems (which form the basis for the ongoing
Million Death Study in India; MDS); strengthening the INDEPTH network of 42 demographic surveillance sites; adding
retrospective COD surveys to the demographic household and health surveys in 90 countries; post-census retrospective
mortality surveys; and for smaller countries, systematic assembly of health records. Lessons learned from the MDS,
especially on low-cost, high-quality methods of verbal autopsy, paired with emerging use of electronic data capture and
other innovations, can make COD systems low-cost and relevant for a wide range of childhood and adult conditions.
Summary: Low-cost systems to obtain and report CODs are possible. If implemented widely, COD systems could
identify disease control priorities, help detect emerging epidemics, enable evaluation of disease control programs,
advance indirect methods, and improve the accountability for expenditures of disease control programs.
Keywords: Causes of death, Cause of death statistics, Mortality, Vital statistics, Verbal autopsy, Sample registration systemBackground
Reliable, reproducible, and openly available information
on age-specific and sex-specific cause of death (COD) is
essential to charting pathways to reduce premature child
and adult mortality [1-5]. The United Nations (UN) esti-
mates that the 48 million deaths in low- and middle-income
countries (LMICs), including about 7 million child deaths,
represent 86% of the 56 million global deaths that occurred
in 2010 [6]. Most deaths in LMICs do not have a diagnosis
of COD [3,7]. Given the limitations of indirect methods to
estimate COD statistics, the most urgent need is to collect
reliable, representative, and robust primary COD data to
guide national and global health action and research. There
are practical ways for LMICs to develop and expand rapidly
the mortality systems that determine the CODs. This paperCorrespondence: prabhat.jha@utoronto.ca
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2014draws on the lessons from various countries, in particular
from the ongoing Indian Million Death Study (MDS) [8,9].
Mortality and causes of death
There are two components to measuring mortality; the
first is capturing the event of death (by at least age and sex,
but ideally including geographical residence and education
or some measure of social status). The second is ascertain-
ing the underlying COD, which is the disease that contrib-
uted most directly to the death (as distinct from immediate
cause or co-existing conditions). Death is a concrete, final,
and measurable event that households remember well, and
it can be captured in household surveys reliably.
Since about 1960, use of population totals from census
data and retrospective mortality estimates, paired with in-
direct demographic methods, has enabled reasonably cred-
ible estimates of the age-specific and sex-specific national
mortality rates for most countries. These are published
and updated regularly by the UN Population Division [6].is an open access article distributed under the terms of the Creative Commons
rg/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and death histories of children, their siblings and parents,
or similar methods [4,10,11], have also improved estimates
of age- and sex-specific mortality, or in some cases specific
causes (such as maternal deaths).
Even rudimentary data on age- and sex-specific all-cause
mortality rates can identify trends for rapidly changing
diseases such as those responsible for childhood mortality
[12]. A simple analysis of the excess death rates between
the 1911 and 1921 censuses in India suggests that the
influenza epidemic of 1918/19 might have killed about
20 million of the population [13]. More recently, it has
been possible to obtain a crude estimate of the effect of
HIV infection on mortality in selected sub-Saharan coun-
tries from the observed large increases in all-cause mortal-
ity rates in young adults from 1990 to 2000, using simple
burial records [14]. In both cases, this was because the
‘signal’ of influenza-attributable or HIV-attributable
mortality (the increase in the number of deaths) exceeded
the ‘noise’ of misclassification by competing mortality from
other causes [15].
Why collect cause of death data?
Over the past century, reliable COD data in high-income
countries have led to numerous discoveries and health im-
provements [1,16-18]. For example, the dramatic increase
in lung cancer deaths in British and American men around
the period of World War II spurred research that led to
the identification of smoking as a cause of lung cancer and,
eventually, a wide range of diseases [19]. In the early 1980s,
routine mortality data from San Francisco identified an
exceptional increase in immune-related deaths in young
men, which signaled the beginning of the American
HIV epidemic [20]. Downward trends in infectious dis-
ease mortality worldwide have reflected the widespread
use of immunizations and antimicrobials [17,18].
Despite these clear benefits, COD data are exceptionally
limited in LMICs because of historical neglect and insuffi-
cient resources. Of 115 countries that reported mortality
data to the World Health Organization (WHO) around
2005, only 64 had good-quality vital registration that
also included COD certification [3]. Fully 75 countries
(including about 90% of African countries) did not provide
data on COD for any year after 1990 (Figure 1). Similarly,
the Child Health Epidemiology Reference Group estimated
that COD information was available for only 3% of global
child deaths [7]. There is a major knowledge gap for repre-
sentative information on COD in adults, such as the
proportion of adult deaths due to malaria [21]. China
and India have nationally representative COD surveys
[9,22,23], and China and Latin America have expanded
civil registration with medical certification. Thus, the major
gap in COD information exists in sub-Saharan Africa and
in South and East Asian countries [3].Seven limitations of indirect methods to estimate COD
In 1981, the Ghana Health Assessment Team [24] advanced
the concept of measuring burden of disease by combining
loss of useful life through premature death with the loss of
useful life due to disability. This spurred further work, most
notably the influential World Development Report 1993 by
the World Bank [25]. The WHO Global Health Estimates
(GHE) [26] use similar approaches to estimate mortality
levels and COD for the major regions of the world, and for
most countries. The 2010 Global Burden of Disease (GBD)
Study goes further by claiming it can make reliable estimates
for ‘291 diseases and injuries, 67 risk factors, and 1,160 non-
fatal health consequences in 21 regions, 20 age groups and
187 countries’ [27]. It is important to understand the
strengths and limitations of these indirect methods.
A simplified schema of how GBD estimates are created is
shown in Figure 2, with the key inputs of mortality totals
(derived from the UN or demographic methods), COD data,
estimates of disability weights for specific conditions (based
largely on expert opinion), and risk factors (based largely
on literature reviews). The GBD uses regression equations
(of uncertain error) to predict the level of mortality, or the dis-
tribution of several CODs from populations (mostly in high-
income countries) for which such data are known. Parameters
for independent variables include economic (GDP/capita),
educational (literacy rates), and other variables such as gene-
ralized HIV epidemic, endemic malaria, and geography,
among others. In parallel, simultaneous equations are used to
model relations between incidence, prevalence, death rate,
duration of disease, and survival, among others, although this
does not directly enable estimations of COD distributions.
The obvious limitation of this indirect method is an insuffi-
cient number of nationally representative COD data. The
2010 GBD [27] study had to apply these complex methods to
a ratio of 1 nationally representative COD to 850 estimated
deaths so as to measure the cause of 25 million deaths, across
110 LMICs outside China, India, and Latin America
(Figure 3). National COD surveys of reasonable repre-
sentativeness used by the GBD were available only from
Afghanistan, India, Mozambique, Thailand, Vietnam, and
Zambia, totaling about 60,000 surveyed annual deaths [27], of
which half were from the MDS in India [9]. Other COD data
sources in the GBD are described scantily, but appear to com-
prise hospital archives on deaths and diseases (a patchwork of
generally small, non-representative surveys), death and cancer
registries, mortuary statistics, and incomplete records from
ministries, census departments, and police reports.
Aside from this key data limitation, the GBD has six
other constraints, as follows:
1) The core COD data are not open source, and it has
not thus far been possible to reproduce GBD results,
limiting scientific confidence in its findings
[2,29-32].
Figure 1 Quality of the cause of death statistics from low- and middle-income countries (LMICs) reported to WHO. Only five countries
outside China, India and Latin America have national COD surveys: Afghanistan, Mozambique, Thailand, Vietnam and Zambia. Zambia's survey covers
4 of 10 provinces. The remaining countries are nationally representative. Source: Mathers et al. [3], updated based on data from Murray et al. [27].
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with true underlying uncertainty, as they have few
robust COD data sources available, and most
importantly, have too few representative COD
surveys. This in turn creates large variations in
individual diseases from unstable models that are
not specific to local country conditions [33]. ForFigure 2 Simplified schema of death and disability estimates in indirectinstance, the 1996 version of the GBD estimated
0.95 million deaths from tuberculosis in India for
the year 2000, whereas the 1999 version estimated
0.42 million deaths for the year 1998 [32]. Similarly,
recent estimates of childhood and adult deaths from
malaria in Africa [34] have partially modeled the
Indian MDS mortality patterns [21] onto the CODmethods. Modified from World Bank data [25].
Figure 3 Cause of death (COD) data in the Global Burden of Disease (GBD) study for selected countries. The GBD measured the major
COD types in 110 low- and middle-income countries (LMICs) based on data available from national surveys with verbal autopsy (VA) in five
countries; final results were based on a ratio of estimated to actual COD data that was less than 0.12% (or about 1 in 850). Most health
measurements rely on disability estimates as opposed to mortality, and measurement error often exceeds the desired change in health outcomes
following an intervention. For example, in seeking a 10% improvement in health outcomes in children under 5 years of age, it is not possible to
accurately assess the outcome of an intervention if the measurement error exceeds 10%. By contrast, as death is a discernible, objective outcome,
restricting analyses to mortality significantly reduces measurement error [1,28].
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underestimation of the extent to which malaria in
Africa kills children, and an overestimation of the
extent to which it kills adults. Similarly, changes in
the reporting of maternal deaths mean that the GBD
estimates of maternal deaths due to human
immunodeficiency virus (HIV) infection vary from
18,000 to 56,000 in adjacent years [35]. Finally, the use
of economic and educational variables in regression
equations might falsely reduce outliers for countries
that produce better mortality outcomes at lower
spending (or vice versa).
3) The models do not adequately capture the underlying
uncertainty in misclassification of CODs, but rather
create somewhat misleading ‘uncertainty intervals’
based on re-running the econometric simulations. Thus,
the GBD has equally narrow estimates for the range of
diabetes deaths in Africa as for those in high-income
countries, despite the obvious paucity in Africa of COD
data or surveys of diabetes prevalence [31].
4) The GBD often rejects real epidemiological data if they
do not fit the models [29,36]. Among Indian womenaged 30 to 69 years, the MDS estimates that 33,000 die
from cervical cancer and 20,000 from breast cancer
[37], whereas the GBD claims that more Indian
women die from breast than from cervical cancer.
5) The total numbers of deaths in the GBD are uncertain
as these too have relied on regression models for
estimation of total mortality. The GBD estimates nearly
3 million fewer deaths in LMICs than does the UN
Population Division for 2010 [6]. The UN and the South
African Medical Research Council estimated a 3% yearly
decrease in childhood mortality in South Africa since
2000, mostly based on direct surveys, whereas the GBD
estimates projected a 3% yearly increase over the same
time period [38]; obviously, both cannot be right.
6) Such indirect estimates, especially when published by
international organizations in major journals, create a
false impression that reliable country-level estimates
are available, and this may inhibit further work to
obtain direct estimates.
Mortality comprises most of the composite of mortality
and disability measures, such as disability-adjusted life years
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orities, such as depression, schizophrenia, or blindness. For
most diseases, the GBD estimates of disability are largely ex-
pert opinion, and thus there is no easy way to validate the
disability estimates or to study the relationship of disability
and death. For example, in comparison to the 1993 World
Bank report [25] or earlier GBD reports, the 2010 version of
the GBD assigns about 2.5 times as many disability adjusted
life years to child deaths [39]. However, the correlation be-
tween premature mortality (specifically death before the age
of 70 years) and morbidity is strong for the majority of
other diseases of public health importance, with only some
exceptions [27,28]. This implies that reliable COD data
should remain the major priority for most LMICs.
Five options to expand COD reporting at low cost and
high impact
For most individual LMICs, the sources of mortality data are
too incomplete, too unrepresentative and of too uncertain
quality for accurate COD estimation at the national level.
Expanding the number of countries with direct COD data is
also the best way to improve indirect estimates, and more
importantly, to assist national public health action and re-
search [1-5,28].
The major objective for most LMICs should be to obtain
representative data on age-, gender-, and social strata-
specific CODs (both total numbers and rates per living
population) for the major diseases. Universal civil registration
of deaths with medical certification remains the best long-
term goal [11], but complete civil registration is achieved
over several decades. Even the USA took the better part of a
century to increase death certification, and some states did
not reach complete coverage until the 1970s [1,16]. Develop-
ing countries have shown little progress in the expansion of
civil registration [11], and COD statistics lag even further be-
hind [4]. Slow progress in civil registration in LMICs is
mostly a result of limited access to medical care and the fact
that most deaths occur at home rather than in hospitals.
Incentives for households to register deaths are limited, be-
cause pension and insurance schemes or enforceable familial
inheritance and property rights are uncommon in LMICs.
Strategies to increase civil registration include increasing
medical attention at death and training existing healthcare
workers to complete death certificates [11]. Requiring burial
or cremation grounds to register deaths is practicable in
urban settings, but currently less so in rural areas. Efforts to
accelerate COD statistics can strengthen civil registration if
they work in concert with national census and statistical or-
ganizations [4,9,11].
There are at least five complementary and practicable
approaches to obtain better COD data in the medium
term (such as by 2025) [1-5].
The first and most robust option (sometimes called Sam-
ple Vital Registration with Verbal Autopsy [8,9]) is theestablishment of a Sample Registration System (SRS). Such a
system has worked in representative areas of India since
1971 [9]. China has a similar but less representative system
[23]. SRSs are able to continuously and prospectively collect
data on the event of death and COD from enrolled house-
holds, enabling reliable determination of mortality rates in
the population. Mortality rates may require adjustment, as in
India, for undercounts that arise from loss to follow-up [40].
SRSs have the disadvantage of requiring more technical
capacity to enable continuous enumeration compared with
retrospective household surveys.
The second option is to strengthen the ongoing
INDEPTH network [41,42] of about 42 demographic
surveillance sites in 19 countries (Figure 4). This would in-
volve efforts to expand the sample size in each country
and make the sites representative of the population, and
to enable prospective collection of deaths. The Adult
Morbidity and Mortality Project in Tanzania was able to
strengthen vital statistics and survey capacity, and enabled
the use of COD data to monitor and evaluate malaria,
HIV/AIDS, and other national programs [42].
The third option is to carry out retrospective surveys of
CODs to supplement the globally standardized Demographic
and Health Surveys (DHS). These surveys were initiated by
the US government about three decades ago, and now cover
about 90 countries (Figure 4, [43]). The addition of COD
information for children to selected DHS has reduced
much of the substantial uncertainty that existed in the 1960s
[7]. DHS sample frames could be used to conduct follow-
up retrospective COD surveys for children and adults.
The fourth option involves carrying out large, well-
planned retrospective surveys of mortality using cen-
sus sample frames. The marked variation in disease in
China became apparent about 3 decades ago, following
a complete national survey of the causes of 20 million
deaths, carried out in the period 1973 to 1975 [44].
This survey yielded the first assessment of age-specific
and cause-specific mortality rates for each province and
county, and for China as a whole. The study showed a
large variation in disease rates across the country, which
in turn brought about health interventions and further re-
search. A similar survey covered about 1 million deaths in
24 urban and 74 rural areas of China during 1986 to 1998
[45]. More recently, Mozambique conducted a national
COD survey of over 11,000 deaths, based on deaths
identified in the preceding census [46].
Finally, in small countries, health departments may
record significantly more deaths and COD data (through
hospitals and community health centers) than is recorded
through civil vital registration, as has been docu-
mented recently for Tonga and Fiji [47-49]. Similarly, a
small number of countries which have reasonable levels of
civil registration of death but more limited COD data,
should consider expanding medically certified COD
Figure 4 Low- and middle-income countries with Demographic and Health Surveys (DHS), INDEPTH network Demographic Surveillance
Sites, or Sample Registration Systems (China and India). Source: INDEPTH [41] and DHS [43], reproduced with permission [1].
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autopsies (VAs) for deaths that occur without medical
attention [1,4].
Lessons learned from the Million Death Study in India
Various countries, notably China and India, have intro-
duced large-scale VA studies [9,23]. The common lesson
from these is the usefulness of even crude COD data
that report on the most important diseases of public
health importance. The MDS in India is a recent and
one of the largest of these VA studies, so lessons from it
are particularly relevant for other countries.
In the absence of reliable COD data, nationally repre-
sentative VA surveys are a viable alternative. VAs involve a
structured investigation of the circumstances and symp-
toms leading to a death, through interviewing an associate
of the deceased during a household survey. VAs have
inherent limitations, particularly the ability to identify only
broad categories of diseases, and a high proportion of
undetermined (or ‘ill-defined’) causes in people aged over
70 years [8,50]. Even in high-income countries, COD at
older ages is difficult to document [51]. However, because
the mean age of death in most LMICs is far lower than
in developed countries, VA remains very relevant for
public health and disease control priorities. With pro-
perly standardized training and data collection, double-
coding by physicians, and other quality controls, the
aggregation of VA data can be extremely powerful at the
population level.
Prior to 2004, it was difficult in India to accurately
assess local health conditions, explore key risk factors,
and evaluate the effects of investments and policies. Toaddress this fundamental gap, the MDS was launched
in 2002 [8,9]. In collaboration with the Registrar General
of India, the MDS applied simple, low-cost methods
(less than US$2 per household) to record COD data
from about 1 million homes throughout the country,
which were randomly selected from the preceding census.
The MDS focused on a simple process using local field
staff who obtained key questions on all deaths, including a
half-page narrative in the local language. These were con-
verted into electronic records and coded independently by
at least two physicians [8,9]. Household participation rates
have averaged close to 100%. Despite the obvious limita-
tions of VA, the COD information in India today is many
times better than the little or no data available previously.
Even crude COD data applied widely to various diseases
and risk factors across an entire country have yielded un-
expected results and influenced disease control priorities.
Some selected results from the MDS and their implica-
tions for disease control are shown below:
 HIV/AIDS resulted in 0.1 million deaths in 2004
(UNAIDS estimated 0.4 million [52]). This result led to
adjustments in AIDS funding to better align with the
actual demand in India for life-prolonging therapies.
 Smoking caused approximately 1 million deaths in
2010 [53]. This finding supported the Indian
government efforts to introduce warning labels on
cigarette packages and to raise tobacco taxes to help
reduce cigarette consumption.
 Malaria caused 0.2 million deaths (13 times the
WHO estimate) in 2005, primarily in adults [21].
Within 1 week, this finding led to public demand
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(and spurred other, currently inconclusive,
research on adult malaria deaths in Africa [34]).
 The survey identified 2 million child deaths in
2005 resulting from five avoidable causes [54].
This finding spurred the expansion of neonatal/
intra-partum care and is presently enabling
district-based monitoring of child deaths and up-
to-date estimates of neonatal mortality by gender
across all districts [55].
 Cervical cancer was the leading cause of cancer
death in adult middle-aged women in 2010 [37],
accounting for 33,000 deaths. If this corresponding
rate were to be reduced to that seen in populations
with low levels of transmission of the causative
human papillomavirus, cervical cancer death
rates in Indian women would be about
two-thirds lower.
 Snakebite kills 50,000 people [56] in India, which
equals the WHO estimate for all snakebite deaths
worldwide. The distribution of snakebite deaths in
specific states suggests that it might be possible to
eliminate or substantially reduce deaths in these
states.
The MDS has three key methodological implications
relevant for other LMICs:
1) There is a need to avoid the false ‘gold standard’ of
hospital CODs. Hospital-based deaths cannot be used
to validate VA, because the age, educational level,
pathogen distribution, and etiology of rural medically-
unattended deaths differs hugely from hospital deaths
[50,57]. Further studies are needed (and planned) to
compare individual- and population-level results from
VA collected by non-medical staff, but coded by a
doctor, against deaths collected and certified by a doc-
tor in rural areas. At the population level, simple but
robust criteria to quantify the performance of VA-
based COD systems are proposed and applied to the
MDS [58].
2) The most practicable and robust measure to capture
the true uncertainty in COD data is the proportion of
ill-defined deaths before old age. It is simply impossible
to know the causes for all deaths, especially those
based on VA. Countries require a balance akin to
St. Augustine’s plea ‘Oh Lord, let me be chaste, but
not quite yet.’ Quality controls over fieldwork and
coding can reduce ill-defined conditions without
artificially eliminating them. Reductions in the
proportion of these ill-defined conditions indicate
improvements in quality, but no ill-defined conditions
indicate fraud or deficiencies in fieldwork [58]. This
further suggests a need to re-examine the GBD andWHO practice of re-assigning the less-defined
codes in the International Classification of Diseases
[59] (sometimes called ‘garbage codes’). Re-assignment
may well muddy COD data by combining truly ill-
defined causes with other, more certain, causes [28].
3) COD systems can also measure risk factors, in
particular for adult CODs. For most infectious
conditions, such as meningitis, the COD is directly
related to the infective agent. By contrast, chronic
diseases such as myocardial infarction may be
caused by several factors such as smoking, raised
blood pressure, or raised blood lipids. Co-morbidity
codes on death certificates [60] have been used in
high-income countries, but completion of these
codes on death certificates in LMICs remains
uncommon. Simply asking about the dead person’s
risk factors can be useful. A retrospective study of
one million deaths in China compared the proportions
of smokers and non-smokers who died of tobacco-
attributable diseases versus non-tobacco-related
diseases (chiefly injuries) to calculate the excess number
of deaths in smokers [45]. These methods have been
extended recently to South Africa [61] and Bangladesh
[62]. Simple questions in the MDS about the deceased’s
risk factors and that of the respondent enabled
household case–control methods to quantify tobacco
smoking, tobacco chewing, and alcohol drinking
hazards in India [53]. The household interviews
required for VA enable the collection at low cost of a
wider range of other exposures, and information on
use of health and other social services.
Household visits are a unique opportunity to obtain
representative information on how people live, and then
to link these to deaths. Geocoding these data provides
unprecedented capability to use geospatial epidemiology
and data-mining approaches to understand disease and
its determinants. Examples of information available from
rapid, standardized interviews of the household include
the following:
1) Childhood immunization, treatment-seeking, service
use, nutrition patterns, and other variables.
2) Maternal contraception and birth-spacing patterns,
and use of maternal services and newer
technologies.
3) Access to and use of HIV, tuberculosis, malaria, and
other services, including use of mosquito nets,
condoms, and other preventive measures.
4) Household nutrition, financial protection, access to
microcredit, and spending or borrowing for disease
treatment.
5) Connectedness with mobile technology, modern
banking, identity schemes, health insurance, and
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6) Simple dried blood spots or oral saliva samples to
enable ‘bio-surveys’ or ‘sero-surveillance’ of various
infections, validate coverage rates against major
antigens, determine prevalence of diseases such as
malaria and dengue, and enable multiplex central
testing [63] of various biological correlates of disease.
Faster, cheaper, and better nationally representative COD
surveys
Information technology, most notably electronic capture
of field data with global positioning satellite tracking and
electronic coding by physicians, biological co-sampling
of deaths, and use of computer algorithms and geospatial
sampling, could substantially improve the validity, reliability,
and feasibility of VA, while simultaneously lowering costs.
Computer-assisted coding is a promising complement to
physician coding, which remains the preferred standard
[64]. Future combinations of algorithms might well improve
or, less certainly, even replace physician coding.
The large-scale demonstration of the technical and polit-
ical feasibility of the MDS, paired with the aforementioned
innovations in COD surveys, suggests that it is possible for
LMICs to adopt at low cost a number of methods to obtain
nationally representative COD data by age and gender. A
key emerging theme is the need for all such data to be fully
and openly available (with protection for individual data
and privacy) to ensure that these may be used imaginatively
and without restriction [65]. A reasonable goal would be to
ensure that all LMICs, but particularly low-income African
and Asian countries, have in place large, simple, nationally
representative surveys of COD by 2025 [66,67] in time to
monitor the proposed replacement for 2030 of the UN
global development goals [39,68].
Summary
Representative and accurate COD information systems
have historically been of huge importance to public health.
Such low-cost systems are possible, and if implemented
widely, can identify disease control priorities, advance
GBD, GHE and other indirect methods, help detect emer-
ging epidemics, enable evaluation of disease control pro-
grams, and improve the accountability for expenditures of
disease control programs [1-5,28].
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